Conclusions
Animal models have been very useful in characterizing the pharmacodynamics of anti-infective drugs
For drug development they are a useful tool for establishing the dosage regimen for Phase II-III clinical trials and susceptibility breakpoints
More studies are needed that correlate PK/PD parameters in animals and humans and measure the impact of different resistant mechanisms on the magnitude of the PK/PD parameter determining efficacy